Excitation-contraction coupling and mitochondrial energetics

被引:208
作者
Maack, Christoph [1 ]
O'Rourke, Brian
机构
[1] Univ Klinikum Saarlandes, Innere Med Klin 3, D-66421 Homburg, Germany
[2] Johns Hopkins Univ, Inst Mol Cardiobiol, Div Cardiol, Baltimore, MD USA
关键词
calcium; sodium; microdomain; heart failure; adenosine triphosphate; adenosine diphosphate; respiration; tricarboxylic acid cycle;
D O I
10.1007/s00395-007-0666-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac excitation-contraction ( EC) coupling consumes vast amounts of cellular energy, most of which is produced in mitochondria by oxidative phosphorylation. In order to adapt the constantly varying workload of the heart to energy supply, tight coupling mechanisms are essential to maintain cellular pools of ATP, phosphocreatine and NADH. To our current knowledge, the most important regulators of oxidative phosphorylation are ADP, Pi, and Ca2+. However, the kinetics of mitochondrial Ca2+- uptake during EC coupling are currently a matter of intense debate. Recent experimental findings suggest the existence of a mitochondrial Ca2+ microdomain in cardiac myocytes, justified by the close proximity of mitochondria to the sites of cellular Ca2+ release, i. e., the ryanodine receptors of the sarcoplasmic reticulum. Such a Ca2+ microdomain could explain seemingly controversial results on mitochondrial Ca2+ uptake kinetics in isolated mitochondria versus whole cardiac myocytes. Another important consideration is that rapid mitochondrial Ca2+ uptake facilitated by microdomains may shape cytosolic Ca2+ signals in cardiac myocytes and have an impact on energy supply and demand matching. Defects in EC coupling in chronic heart failure may adversely affect mitochondrial Ca2+ uptake and energetics, initiating a vicious cycle of contractile dysfunction and energy depletion. Future therapeutic approaches in the treatment of heart failure could be aimed at interrupting this vicious cycle.
引用
收藏
页码:369 / 392
页数:24
相关论文
共 221 条
[31]   Effect of changes in action potential spike configuration, junctional sarcoplasmic reticulum micro-architecture and altered t-tubule structure in human heart failure [J].
Cannell, M. B. ;
Crossman, D. J. ;
Soeller, C. .
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 2006, 27 (5-7) :297-306
[32]   SPATIAL NONUNIFORMITIES IN [CA2+](I) DURING EXCITATION-CONTRACTION COUPLING IN CARDIAC MYOCYTES [J].
CANNELL, MB ;
CHENG, H ;
LEDERER, WJ .
BIOPHYSICAL JOURNAL, 1994, 67 (05) :1942-1956
[33]   Mitochondrial free calcium transients during excitation-contraction coupling in rabbit cardiac myocytes [J].
Chacon, E ;
Ohata, H ;
Harper, IS ;
Trollinger, DR ;
Herman, B ;
Lemasters, JJ .
FEBS LETTERS, 1996, 382 (1-2) :31-36
[34]   Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions [J].
Chaitman, Bernard R. .
CIRCULATION, 2006, 113 (20) :2462-2472
[35]  
CHAMBERLAIN BK, 1984, J BIOL CHEM, V259, P7547
[36]  
CHANCE B, 1965, J BIOL CHEM, V240, P2729
[37]   METHOD FOR THE LOCALIZATION OF SITES FOR OXIDATIVE PHOSPHORYLATION [J].
CHANCE, B ;
WILLIAMS, GR .
NATURE, 1955, 176 (4475) :250-254
[38]   Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure [J].
Chandler, MP ;
Stanley, WC ;
Morita, H ;
Suzuki, G ;
Roth, BA ;
Blackburn, B ;
Wolff, A ;
Sabbah, HN .
CIRCULATION RESEARCH, 2002, 91 (04) :278-280
[39]  
Chazov E I, 1980, Adv Myocardiol, V1, P139
[40]   Inhibition and reversal of myocardial infarction-induced hypertrophy and heart failure by NHE-1 inhibition [J].
Chen, L ;
Chen, CX ;
Gan, XHT ;
Beier, N ;
Scholz, W ;
Karmazyn, M .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 286 (01) :H381-H387